Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
28.01.2009 21:10:00

Lam Research Corporation Announces Financial Results for the Quarter Ended December 28, 2008

Lam Research Corporation (NASDAQ:LRCX) highlights for the December 2008 quarter were:

(in thousands, except per share data and percentages)
       
? Revenue: $ 283,409
 
? Operating Margin: U.S. GAAP: -13.2 % Ongoing: -6.1 %
 
? Net Loss: U.S. GAAP: $ (24,172 ) Ongoing: $ (11,748 )
 
? Diluted EPS: U.S. GAAP: $ (0.19 ) Ongoing: $ (0.09 )

Lam Research Corporation today announced financial results for the quarter ended December 28, 2008. Revenue for the period was $283.4 million, gross margin was $101.4 million and net loss was $(24.2) million, or $(0.19) per diluted share, compared to revenue of $440.4 million, gross margin of $183.1 million and net income of $8.9 million, or $0.07 per diluted share, for the September 2008 quarter. Shipments for the December 2008 quarter were $226 million compared to $345 million during the September 2008 quarter.

The Company’s ongoing results for the December 2008 quarter exclude certain costs for restructuring activities and asset impairments designed to better align the Company’s cost structure with its business opportunities in consideration of market and economic uncertainties, a net tax benefit related to the renewal of the research and development tax credit, net tax expense on resolution of certain tax items, one-time costs associated with the restructuring of an employee benefit plan, exchange rate loss associated with the Company’s accelerated tax planning strategy, and interest on the tax liability associated with the outcome of the Company’s previously disclosed voluntary internal stock option review. The Company’s September 2008 quarter excluded certain costs for restructuring activities and asset impairments related to the integration of SEZ, net tax expense on accelerated tax planning strategy, and interest on the tax liability associated with the outcome of the Company’s previously disclosed voluntary internal stock option review. Management uses the presentation of ongoing gross margin, ongoing operating income, ongoing net income, and ongoing diluted earnings per share to evaluate the Company’s operating and financial results. The Company believes the presentation of ongoing results is useful to investors for analyzing ongoing business trends and comparing performance to prior periods, and enhances the investor’s ability to view the Company’s results from management’s perspective. A table presenting a reconciliation of ongoing results to results under U.S. GAAP is included at the end of this press release and on the Company’s web site.

Ongoing net loss was $(11.7) million, or $(0.09) per diluted share in the December 2008 quarter compared to ongoing net income of $32.6 million, or $0.26 per diluted share, for the September 2008 quarter. Ongoing gross margin for the December 2008 quarter was $109.1 million or 38.5%, compared to ongoing gross margin of $186.2 million, or 42.3%, for the September 2008 quarter. The sequential decline in gross margin was primarily due to reduced manufacturing and field utilization levels and product mix challenges resulting from the reduced business activity. Ongoing operating expenses for the December 2008 quarter decreased to $126.5 million compared with the September 2008 quarter of $149.9 million. This decrease was driven by a reduction in employee variable compensation expenses, a reduction in deferred compensation liabilities due to recent stock market declines, and the partial quarter impact of the Company’s December quarter restructuring activities.

The geographic distribution of shipments and revenue during the December 2008 quarter is shown in the following table:

Region   Shipments   Revenue
North America 17 % 15 %
Europe 12 % 10 %
Japan 22 % 28 %
Korea 17 % 22 %
Asia Pacific 32 % 25 %

Cash and cash equivalents, short-term investments and restricted cash and investments balances were $1.1 billion at the end of the December 2008 quarter, compared to $1.2 billion at the end of the September 2008 quarter. Cash flows from operating activities were approximately $(39.0) million during the December quarter. Deferred revenue and deferred profit balances at the end of the December 2008 quarter were $68.4 million and $54.2 million, respectively. At the end of the December 2008 quarter, the anticipated future revenue value of orders shipped to Japanese customers that was not recorded as deferred revenue was approximately $8.6 million.

"The global semiconductor industry has entered one of the most difficult periods in its history, one that is presenting severe challenges to our customers and thus severely limiting investment in wafer fab equipment,” said Steve Newberry, Lam’s president and chief executive officer. "While this environment will persist near-term, we remain optimistic about our long-term technology roadmap in etch, clean and other new markets. During the pause in customer spending we are strategically targeting our capital resources to new penetration opportunities, qualifying our next-generation tools and delivering cost-effective technology solutions aimed at reducing our customers’ production costs. Our objective through these actions is to deliver superior value to our customers and emerge from this period of reduced spending well positioned to deliver strong financial and operational performance,” Newberry concluded.

Statements made in this press release which are not statements of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate, but are not limited, to our ability to align our cost structure with our business opportunities, our future plans, areas of focus, and technology roadmap, our expectations for our ability to deliver long term strong financial and operational performance, our belief that our efforts will help us emerge from the current environment in a strong position to enable future revenue and profit growth, and our ability to succeed in delivering cost effective technology solutions to our customers. Some factors that may affect these forward-looking statements include: difficult business conditions in the semiconductor industry and the overall economy and the efficacy of our plans for reacting to those conditions, factors that tend to make our quarterly results more volatile (such as exchange rate fluctuations), changing customer demands, and the challenges presented by our new products and the integration of acquired businesses and technologies into our existing business. These forward-looking statements are based on current expectations and are subject to uncertainties and changes in condition, significance, value and effect as well as other risks detailed in documents filed with the Securities and Exchange Commission, including specifically the report on Form 10-K for the year ended June 29, 2008, and Form 10-Q for the quarter ended September 28, 2008, which could cause actual results to vary from expectations. The Company undertakes no obligation to update the information or statements made in this press release.

Lam Research Corporation is a major provider of wafer fabrication equipment and services to the world’s semiconductor industry. Lam’s common stock trades on The Nasdaq Global Select Market SM under the symbol LRCX. Lam is a NASDAQ-100 ® company. For more information, visit www.lamresearch.com.

LAM RESEARCH CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
(unaudited)
         
Three Months Ended Six Months Ended
December 28, September 28, December 23, December 28, December 23,
  2008     2008     2007     2008     2007  
Total revenue $ 283,409 $ 440,361 $ 610,320 $ 723,770 $ 1,294,941
Cost of goods sold 174,329 254,203 302,659 428,532 643,393
Cost of goods sold - restructuring and asset impairments   7,728     3,048     -     10,776     -  
Total cost of goods sold 182,057 257,251 302,659 439,308 643,393
Gross margin 101,352 183,110 307,661 284,462 651,548
Gross margin as a percent of revenue 35.8 % 41.6 % 50.4 % 39.3 % 50.3 %
Research and development 68,781 81,563 80,243 150,344 156,531
Selling, general and administrative 59,842 69,060 66,084 128,902 135,797
Restructuring and asset impairments   10,121     15,968     -     26,089     -  
Total operating expenses   138,744     166,591     146,327     305,335     292,328  
Operating income (loss) (37,392 ) 16,519 161,334 (20,873 ) 359,220
Operating margin as a percent of revenue -13.2 % 3.8 % 26.4 % -2.9 % 27.7 %
Other income (expense), net   (7,233 )   9,017     (37 )   1,784     7,596  
Income (loss) before income taxes (44,625 ) 25,536 161,297 (19,089 ) 366,816
Income tax expense (benefit)   (20,453 )   16,663     46,238     (3,790 )   103,169  
Net income (loss) $ (24,172 ) $ 8,873   $ 115,059   $ (15,299 ) $ 263,647  
Net income (loss) per share:
Basic net income (loss) per share $ (0.19 ) $ 0.07   $ 0.92   $ (0.12 ) $ 2.12  
Diluted net income (loss) per share $ (0.19 ) $ 0.07   $ 0.91   $ (0.12 ) $ 2.08  
Number of shares used in per share calculations:
Basic   125,084     125,527     124,685     125,266     124,370  
Diluted   125,084     126,819     126,653     125,266     126,523  
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
     
December 28, September 28, June 29,
  2008   2008   2008
(unaudited) (unaudited)

(1)

ASSETS
Cash and cash equivalents $ 652,913 $ 745,432 $ 732,537
Short-term investments 297,399 313,803 326,199
Accounts receivable, net 290,565 311,633 412,356
Inventories 269,959 272,215 282,218
Deferred income taxes 93,002 95,186 96,748
Other current assets   56,648   69,983   67,649
Total current assets 1,660,486 1,808,252 1,917,707
Property and equipment, net 233,250 230,377 235,735
Restricted cash and investments 168,405 156,148 146,072
Deferred income taxes 25,836 33,762 19,793
Goodwill and intangible assets 371,987 374,538 403,187
Other assets   78,457   81,493   84,261
Total assets $ 2,538,421 $ 2,684,570 $ 2,806,755
 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities $ 446,412 $ 533,722 $ 637,679
 
Long-term debt and capital leases $ 257,135 $ 269,256 $ 276,121
Income taxes payable 92,382 94,184 85,611
Other long-term liabilities 21,300 21,875 23,400
Minority interests - 4,789 5,347
Stockholders' equity   1,721,192   1,760,744   1,778,597
Total liabilities and stockholders' equity $ 2,538,421 $ 2,684,570 $ 2,806,755
 
1 Derived from audited financial statements
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
         
Three Months Ended Six Months Ended
December 28, September 28, December 23, December 28, December 23,
  2008     2008     2007     2008     2007  
 
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss) $ (24,172 ) $ 8,873 $ 115,059 $ (15,299 ) $ 263,647
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
 
Depreciation and amortization 17,177 17,896 11,324 35,073 22,563
Deferred income taxes 10,110 (12,407 ) 776 (2,297 ) (10,014 )
Equity-based compensation expense 14,049 15,408 9,813 29,457 20,615
Income tax benefit on equity-based compensation plans (7,045 ) 5,039 21,277 (2,006 ) 57,177
Excess tax benefit on equity-based compensation plans 3,752 (4,269 ) (16,488 ) (517 ) (37,639 )
Restructuring and asset impairments 17,849 19,016 - 36,865 -
Other, net 3,200 2,665 9,939 5,865 11,316
Changes in operating asset accounts   (73,909 )   (9,089 )   (130,260 )   (82,998 )   (83,778 )
Net cash provided by (used for) operating activities   (38,989 )   43,132     21,440     4,143     243,887  
 
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets (12,417 ) (15,151 ) (24,417 ) (27,568 ) (38,561 )
Acquisitions of businesses, net of cash acquired (8,763 ) (2,427 ) - (11,190 ) -
Net sales (purchases) of available-for-sale securities 39,767 6,980 (15,900 ) 46,747 (31,885 )
Purchase of call option - - (10,279 ) - (10,279 )
Purchases of other investments - - (4,560 ) - (4,560 )
Other (2,000 ) - (2,248 ) (2,000 ) (2,248 )
Transfer of restricted cash and investments   (32,178 )   (16,128 )   (1,074 )   (48,306 )   (1,074 )
Net cash used for investing activities   (15,591 )   (26,726 )   (58,478 )   (42,317 )   (88,607 )
 
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on long-term debt and capital lease obligations (13,060 ) (2,390 ) (51 ) (15,450 ) (100 )
Net proceeds from issuance of long-term debt 515 127 - 642 -
Excess tax benefit on equity-based compensation plans (3,752 ) 4,269 16,488 517 37,639
Treasury stock purchases (24,448 ) (2,755 ) (761 ) (27,203 ) (10,225 )
Reissuances of treasury stock - 7,584 - 7,584 7,301
Proceeds from issuance of common stock   1,294     3,150     3,398     4,444     10,106  
Net cash provided by (used for) financing activities   (39,451 )   9,985     19,074     (29,466 )   44,721  
Effect of exchange rate changes on cash 1,512 (13,496 ) 851 (11,984 ) 2,087
Net increase (decrease) in cash and cash equivalents (92,519 ) 12,895 (17,113 ) (79,624 ) 202,088
Cash and cash equivalents at beginning of period   745,432     732,537     793,168     732,537     573,967  
Cash and cash equivalents at end of period $ 652,913   $ 745,432   $ 776,055   $ 652,913   $ 776,055  
Reconciliation of U.S. GAAP Net Income (Loss) to Ongoing Net Income (Loss)
(in thousands, except per share data and percentages)
   
Three Months Ended Three Months Ended
December 28, September 28,
  2008     2008  
U.S. GAAP net income (loss) $ (24,172 ) $ 8,873
Pre-tax non-ongoing items:
Restructuring and asset impairments - cost of goods sold 7,728 3,048
Restructuring and asset impairments - operating expenses 10,121 15,968
Restructuring of employee benefit plan - operating expenses 1,300 -
Voluntary internal stock option review - operating expenses 843 761
Exchange rate loss associated with accelerated tax planning strategy - other income (expense), net 7,569 -
Net tax benefit on non-ongoing items (7,375 ) (5,325 )
Net tax benefit on renewal of r&d tax credit (5,751 ) -
Net tax expense on resolution of certain tax matters 1,396 -
Net tax expense (benefit) on accelerated tax planning strategy   (3,407 )   9,310  
Ongoing net income (loss) $ (11,748 ) $ 32,635  
Ongoing net income (loss) per diluted share $ (0.09 ) $ 0.26  
Number of shares used for diluted per share calculation 125,084 126,819
U.S. GAAP income tax rate 45.8 % 65.3 %
Ongoing income tax rate 31.2 % 28.0 %
 
 
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income (Loss) to Ongoing Gross Margin, Operating Expenses and Operating Income (Loss)
(in thousands, except percentages)
 
Three Months Ended Three Months Ended
December 28, September 28,
  2008     2008  
U.S. GAAP gross margin $ 101,352 $ 183,110
Pre-tax non-ongoing items:
Restructuring and asset impairments - cost of goods sold   7,728     3,048  
Ongoing gross margin $ 109,080   $ 186,158  
U.S. GAAP gross margin as a percent of revenue 35.8 % 41.6 %
Ongoing gross margin as a percent of revenue 38.5 % 42.3 %
U.S. GAAP operating expenses $ 138,744 $ 166,591
Pre-tax non-ongoing items:
Restructuring and asset impairments - operating expenses (10,121 ) (15,968 )
Restructuring of employee benefit plan - operating expenses (1,300 ) -
Voluntary internal stock option review - operating expenses   (843 )   (761 )
Ongoing operating expenses $ 126,480   $ 149,862  
Ongoing operating income (loss) $ (17,400 ) $ 36,296  
Ongoing operating income (loss) as a percent of revenue -6.1 % 8.2 %

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Analysen zu Lam Research Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Lam Research Corp. 720,00 -0,54% Lam Research Corp.

Indizes in diesem Artikel

NASDAQ Comp. 19 011,85 0,21%
NASDAQ 100 20 782,45 0,20%
S&P 400 MidCap 1 854,40 -0,45%